Seratrodast, also known as AA-2414, is a potent and selective antagonist of the TXA2R (thromboxane A2 receptor). Seratrodast is described to produce antioxidant effects, and is demonstrated to inhibit peroxide-induced vasoconstriction in human placenta. Additionally, it inhibit bronchoconstriction in guinea pigs in response to leukotriene D4, U-46619, and platelet activating factor.
参考文献
1. Ashida, Y., et al. 1989. Prostaglandins. 38: 91-112. PMID: 2748922
2. Kurokawa, T., et al. 1994. Biol. Pharm. Bull. 17: 383-385. PMID: 8019502
3. Hussein, Z., et al. 1994. Clin. Pharmacol. Ther. 55: 441-450. PMID: 8162671
4. Walsh, S.W., et al. 1999. J. Pharmacol. Exp. Ther. 290: 220-226. PMID: 10381779
5. Cui, S., et al. 2007. Eur. J. Pharmacol. 576: 99-106. PMID: 17706964